SMARCE1 Knockout HEK293 Cell Line
Cat.No.:
EDC90425
Species:
Human
Cell Name:
HEK293
Gene:
SMARCE1
Gene ID:
6605
Size:
1×10⁶ cells
SMARCE1 Knockout Cell Line (HEK293) is an exclusive upgraded CRISPR/Cas9 system-mediated gene knockout cell, with the advantages of Optimized Strategy Design, Efficient Cell Transfection, High-Performance Cas9 Protein and Hassle-Free Cell Selection.
| Cat.No. | EDC90425 |
|---|---|
| Product Name | SMARCE1 Knockout HEK293 Cell Line |
| Cell Line | HEK293 |
| Cellosaurus ID | CVCL_0045 |
| Cell Line Synonyms | Hek293, HEK-293, HEK/293, (HEK)293, HEK 293, HEK,293, 293, 293 HEK, 293 Ad5, Graham 293, Graham-293, Human Embryonic Kidney 293 |
| Gene | |
| NCBI Gene ID | |
| Gene Synonyms | BAF57|CSS5 |
| Summary |
The protein encoded by this gene is part of the large ATP-dependent chromatin remodeling complex SWI/SNF, which is required for transcriptional activation of genes normally repressed by chromatin. The encoded protein, either alone or when in the SWI/SNF complex, can bind to 4-way junction DNA, which is thought to mimic the topology of DNA as it enters or exits the nucleosome. The protein contains a DNA-binding HMG domain, but disruption of this domain does not abolish the DNA-binding or nucleosome-displacement activities of the SWI/SNF complex. Unlike most of the SWI/SNF complex proteins, this protein has no yeast counterpart. [provided by RefSeq, Jul 2008]
|
| Associated Diseases | Non-tumor |
| Morphology | Adherent |
| Passage Ratio | 1/2~1/4 |
| Complete Culture Medium | DMEM + 10% FBS |
| Freezing Medium | 95% Complete Culture Medium+ 5% DMSO |
| QC | Indels validated by Sanger sequencing; sterility confirmed via microbial testing. |
* For research use only. Not intended for use in humans or animals, including clinical, therapeutic, or diagnostic purposes.
| Loci | STR Info (Sample Cell) Sample Cell Line: HEK293 | STR Info (Cell bank) Cell Line: HEK293 | ||
| Allele1 | Allele2 | Allele1 | Allele2 | |
| Amelogenin | X | X | ||
| CSF1P0 | 12 | 11 | 12 | |
| D2S1338 | 19 | 19 | ||
| D3S1358 | 15 | 17 | 15 | 17 |
| D5S818 | 8 | 8 | 9 | |
| D7S820 | 11 | 12 | 11 | 12 |
| D8S1179 | 12 | 14 | 12 | 14 |
| D13S317 | 12 | 14 | 12 | 14 |
| D16S539 | 9 | 13 | 9 | 13 |
| D18S51 | 17 | 18 | 17 | 18 |
| D19S433 | 15 | 18 | 15 | 18 |
| D21S11 | 28 | 30.2 | 28 | 30.2 |
| FGA | 23 | 23 | ||
| Penta D | 9 | 10 | 9 | 10 |
| Penta E | 7 | 15 | 7 | 15 |
| TH01 | 7 | 9.3 | 7 | 9.3 |
| TPOX | 11 | 11 | ||
| vWA | 16 | 19 | 16 | 19 |
| D6S1043 | 11 | 11 | ||
| D12S391 | 19 | 21 | 11 | 15 |
| D2S441 | 11 | 15 | 11 | 15 |
* STR authentication data of this cell line matches with that of cell lines sourced from ATCC, DSMZ, JCRB, and RIKEN databases.
Conclusion: The STR identification of this cell is correct.
Conclusion: The STR identification of this cell is correct.
FAQ
Which is better for studying SMARCE1 function, SMARCE1 Knockout HEK293 Cell Line or SMARCE1 overexpression HEK293 Cell Line?
The choice depends on whether you are studying SMARCE1's role in the BAF (SWI/SNF) chromatin remodeling complex or its emerging functions in cancer biology, particularly in meningioma and small cell carcinoma of the ovary. The Knockout line is appropriate for asking whether SMARCE1 is required for BAF complex assembly and chromatin remodeling activity. Overexpression is useful for studying SMARCE1's role as a context-dependent transcriptional co-regulator.
For chromatin remodeling research, the EDITGENE SMARCE1 Knockout in HEK293 provides a mechanistic platform — HEK293 supports the high-quality ChIP and biochemical analyses needed for BAF complex characterization. SMARCE1 mutations cause familial meningioma (clear cell subtype) and SCCOHT — disease variant rescue enables genotype-function studies. Rescue with wild-type or HMG-domain-mutant SMARCE1 enables structure-function dissection.
What are the application scenarios for this model?
Primary applications:
• BAF complex composition: glycerol gradient or size-exclusion chromatography analysis of BAF complex integrity in the absence of SMARCE1.
• ChIP-seq for BAF subunits: chromatin occupancy mapping of remaining BAF components following SMARCE1 loss to assess targeting defects.
• Disease modeling: rescue with meningioma- or SCCOHT-associated SMARCE1 variants for genotype-function studies.
• Synthetic lethality screening: combinatorial CRISPR screens to identify SMARCE1-loss vulnerabilities relevant to cancer therapy.
EDITGENE recommends this model for researchers investigating BAF (SWI/SNF) complex biology, SMARCE1-related cancers, and chromatin remodeling mechanisms.
Is this SMARCE1 Knockout HEK293 Cell Line compatible with overexpression rescue experiments?
Yes. SMARCE1 rescue experiments require attention to BAF complex assembly:
• Construct design: use a codon-modified SMARCE1 sequence with a small C-terminal tag (FLAG, HA). The N-terminal HMG-like domain mediates DNA binding and protein interactions — large N-terminal tags should be avoided.
• HMG-domain-mutant rescue: HMG-box mutations affecting DNA binding distinguish DNA-engagement-dependent functions from scaffolding roles.
• Disease mutation rescue: meningioma-associated (clear cell subtype) and SCCOHT-associated SMARCE1 variants enable genotype-function studies.
• Functional readout: rescue should restore BAF complex composition (assessed by glycerol gradient) and chromatin occupancy of other BAF subunits.
HEK293 transduces efficiently with lentivirus and supports the biochemical assays needed for BAF complex characterization.
* Research Use Disclaimer: Content is generated from publicly available research data, bioinformatic resources, and computational analyses for research reference only.
download